ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,322,713 | -22.5% | 198,011 | -2.7% | 0.00% | -100.0% |
Q2 2023 | $1,706,853 | +19.8% | 203,439 | +41.8% | 0.00% | – |
Q1 2023 | $1,424,279 | +45.9% | 143,432 | +2.3% | 0.00% | – |
Q4 2022 | $976,000 | +378.4% | 140,232 | +267.1% | 0.00% | – |
Q3 2022 | $204,000 | +110.3% | 38,200 | +57.9% | 0.00% | – |
Q2 2022 | $97,000 | -29.2% | 24,200 | -21.4% | 0.00% | – |
Q1 2022 | $137,000 | +11.4% | 30,800 | 0.0% | 0.00% | – |
Q4 2021 | $123,000 | -69.5% | 30,800 | -32.9% | 0.00% | – |
Q3 2021 | $403,000 | -21.0% | 45,900 | -0.2% | 0.00% | – |
Q2 2021 | $510,000 | +79.6% | 46,000 | +92.5% | 0.00% | – |
Q1 2021 | $284,000 | -73.7% | 23,900 | -84.8% | 0.00% | – |
Q4 2020 | $1,081,000 | -38.4% | 157,558 | -33.4% | 0.00% | -100.0% |
Q3 2020 | $1,754,000 | +2207.9% | 236,674 | +1182.6% | 0.00% | – |
Q2 2020 | $76,000 | -91.4% | 18,453 | -82.6% | 0.00% | – |
Q4 2018 | $879,000 | -23.2% | 105,967 | +27.9% | 0.00% | – |
Q3 2018 | $1,144,000 | – | 82,882 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |